Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
8 hedge funds and large institutions have $718K invested in Plus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
7% less capital invested
Capital invested by funds: $768K → $718K (-$50K)
20% less funds holding
Funds holding: 10 → 8 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
| 2 |
Two Sigma Advisers
New York
|
+$98.3K |
| 3 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
+$32.4K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$7.1K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$214K |
| 2 |
Two Sigma Investments
New York
|
-$114K |
| 3 |
VF
Virtu Financial
New York
|
-$37K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $290K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $185K | +$151K | +149 | +261% |
|
|
3
Two Sigma Advisers
New York
| $147K | +$98.3K | +97 | +147% |
|
|
4
Creative Planning
Overland Park,
Kansas
| $39K | +$7.1K | +7 | +19% |
|
|
BRWM
5
B. Riley Wealth Management
Memphis,
Tennessee
| $29K | +$32.4K | +32 | New |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| $19K | +$5.07K | +5 | +31% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $5K | +$4.05K | +4 | +400% |
|
8
Bank of America
Charlotte,
North Carolina
| $3K | +$4.05K | +4 | New |
|
|
FP
9
Financial Perspectives
Minneapolis,
Minnesota
| $1K | – | – | – |
|
|
10
Renaissance Technologies
New York
| – | -$214K | -283 | Closed |
|
|
11
Two Sigma Investments
New York
| – | -$114K | -151 | Closed |
|
|
VF
12
Virtu Financial
New York
| – | -$37K | -49 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$25K | -33 | Closed |
|
PSTV Hedge Fund Activity: Q1 2021 in Review
8 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q1 2021, worth a combined $718K — down 6.5% from $768K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PSTV and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $151K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $214K sold.
- 8 institutional investors held Plus Therapeutics (PSTV) as of Q1 2021, down from 10 in Q4 2020.
- Funds reported $718K of Plus Therapeutics stock for Q1 2021, down 6.5% quarter-over-quarter.
- 2 funds opened new Plus Therapeutics positions in Q1 2021 and 4 closed out, a net change of -2 holders.
- The largest Plus Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $151K added.
- The largest Plus Therapeutics seller in Q1 2021 was Renaissance Technologies, an estimated $214K sold.
Based on aggregated 13F filings for Q1 2021.